These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17718861)

  • 41. Low frequency of defective mismatch repair in a population-based series of upper urothelial carcinoma.
    Ericson KM; Isinger AP; Isfoss BL; Nilbert MC
    BMC Cancer; 2005 Mar; 5():23. PubMed ID: 15740628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colorectal adenomas in young patients: microsatellite instability is not a useful marker to detect new cases of Lynch syndrome.
    Ferreira S; Claro I; Lage P; Filipe B; Fonseca R; Sousa R; Francisco I; Chaves P; Albuquerque C; Leitão CN
    Dis Colon Rectum; 2008 Jun; 51(6):909-15. PubMed ID: 18306971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
    Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
    Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers.
    Schwitalle Y; Kloor M; Eiermann S; Linnebacher M; Kienle P; Knaebel HP; Tariverdian M; Benner A; von Knebel Doeberitz M
    Gastroenterology; 2008 Apr; 134(4):988-97. PubMed ID: 18395080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer.
    Vahteristo P; Ojala S; Tamminen A; Tommiska J; Sammalkorpi H; Kiuru-Kuhlefelt S; Eerola H; Aaltonen LA; Aittomäki K; Nevanlinna H
    J Med Genet; 2005 Apr; 42(4):e22. PubMed ID: 15805151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Recognition of congenital endometrial carcinoma: the importance of family history and investigation of microsatellite instability in the tumour].
    Hoogerbrugge N; Overbeek LI; de Hullu J; Kets CM; Hebeda KM; Ligtenberg MJ
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1441-4. PubMed ID: 17633970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical and molecular consequences of microsatellite instability in human cancers].
    Hamelin R; Chalastanis A; Colas C; El Bchiri J; Mercier D; Schreurs AS; Simon V; Svrcek M; Zaanan A; Borie C; Buhard O; Capel E; Zouali H; Praz F; Muleris M; Fléjou JF; Duval A
    Bull Cancer; 2008 Jan; 95(1):121-32. PubMed ID: 18230578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient's age or other clinical characteristics.
    Orta L; Klimstra DS; Qin J; Mecca P; Tang LH; Busam KJ; Shia J
    Am J Surg Pathol; 2009 Jun; 33(6):934-44. PubMed ID: 19342947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.
    Barrow E; Alduaij W; Robinson L; Shenton A; Clancy T; Lalloo F; Hill J; Evans DG
    Clin Genet; 2008 Sep; 74(3):233-42. PubMed ID: 18554281
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional analysis of HNPCC-related missense mutations in MSH2.
    Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
    Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers.
    Woerner SM; Kloor M; Schwitalle Y; Youmans H; Doeberitz Mv; Gebert J; Dihlmann S
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1080-9. PubMed ID: 17726700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detecting Lynch syndrome by pathologists.
    van Krieken JH; Kets CM; Ligtenberg MJ; Hoogerbrugge N
    Verh Dtsch Ges Pathol; 2007; 91():104-11. PubMed ID: 18314603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer.
    Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Scand J Gastroenterol; 2007 May; 42(5):628-32. PubMed ID: 17454884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Germline MSH6 mutations are more prevalent in endometrial cancer patient cohorts than hereditary non polyposis colorectal cancer cohorts.
    Devlin LA; Graham CA; Price JH; Morrison PJ
    Ulster Med J; 2008 Jan; 77(1):25-30. PubMed ID: 18269114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome).
    Lynch HT; Lynch JF; Lynch PM
    J Natl Cancer Inst; 2007 Feb; 99(4):261-3. PubMed ID: 17312298
    [No Abstract]   [Full Text] [Related]  

  • 56. Do MSH6 mutations contribute to double primary cancers of the colorectum and endometrium?
    Charames GS; Millar AL; Pal T; Narod S; Bapat B
    Hum Genet; 2000 Dec; 107(6):623-9. PubMed ID: 11153917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ovarian cancer of endometrioid type as part of the MSH6gene mutation phenotype.
    Suchy J; Kurzawski G; Jakubowska A; Lubiński J
    J Hum Genet; 2002; 47(10):529-31. PubMed ID: 12376742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual role of LOH at MMR loci in hereditary non-polyposis colorectal cancer?
    Sanchez de Abajo A; de la Hoya M; van Puijenbroek M; Godino J; Díaz-Rubio E; Morreau H; Caldes T
    Oncogene; 2006 Mar; 25(14):2124-30. PubMed ID: 16288214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimating cancer risk in HNPCC by the GRL method.
    Alarcon F; Lasset C; Carayol J; Bonadona V; Perdry H; Desseigne F; Wang Q; Bonaïti-Pellié C
    Eur J Hum Genet; 2007 Aug; 15(8):831-6. PubMed ID: 17473834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. No evidence for dual role of loss of heterozygosity in hereditary non-polyposis colorectal cancer.
    Tuupanen S; Karhu A; Järvinen H; Mecklin JP; Launonen V; Aaltonen LA
    Oncogene; 2007 Apr; 26(17):2513-7. PubMed ID: 17043646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.